HIF1A and breast carcinoma: One study showed that fibroblasts transformed with constitutively active HIF-1α mutant promote the in vivo growth of co-injected MDA-MB-231 breast cancer cells via enhanced aerobic glycolysis and paracrine production of nutrients [78].